Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses

PLoS ONE

Volumn 4, Issue 8, 2009, Pages

  Nayak, Baibaswata ^a   Rout, Subrat N ^a   Kumar, Sachin ^a   Khalil, Mohammed S ^c   Fouda, Moustafa M ^c   Ahmed, Luay E ^c   Earhart, Kenneth C ^d   Perez, Daniel R ^a   Collins, Peter L ^b   Samal, Siba K ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c Ministry of Environment   (Egypt)

^d US Naval Medical Research Unit No 3 Egypt   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; INFLUENZA VACCINE; RECOMBINANT PROTEIN H5; UNCLASSIFIED DRUG; VIRUS HEMAGGLUTININ; VIRUS VECTOR; INFLUENZA VIRUS HEMAGGLUTININ; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; CYTOPLASM; EMBRYO; GENE EXPRESSION; GENE INSERTION; HUMAN; HUMAN CELL; IMMUNIZATION; INFLUENZA; INFLUENZA VIRUS A H5N1; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; OPEN READING FRAME; PROTEIN DOMAIN; PROTEIN MODIFICATION; SINGLE DRUG DOSE; VIRUS ENVELOPE; VIRUS RECOMBINANT; VIRUS STRAIN; VIRUS VIRULENCE; ANIMAL; BIOSYNTHESIS; CHICKEN; IMMUNOELECTRON MICROSCOPY; IMMUNOLOGY; PATHOGENICITY; VIRULENCE;

ANIMALIA; AVES; AVIAN INFLUENZA VIRUS; GALLUS GALLUS; NEWCASTLE DISEASE VIRUS;

ANIMALS; ANTIBODIES, VIRAL; CHICKENS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS, H5N1 SUBTYPE; MICROSCOPY, IMMUNOELECTRON; NEWCASTLE DISEASE VIRUS; VIRULENCE;

EID: 68349148002     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006509     Document Type: Article

References (36)

1. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y (1992) Evolution and ecology of influenza A viruses. Microbiol Rev 56: 152-179.
2. Fouchier RA, Munster V, Wallensten A, Bestebroer TM, Herfst S, et al. (2005) Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 79: 2814-2822.
3. OIE (2009) Avian Influenza: Facts & Figures 62 Countries Report H5N1 Avian Influenza in Domestic Poultry/Wildlife 2003-2009. http://www.oie.int/eng/info_ev/en_AI_factoids_2.htm.
4. WHO (2009) Cumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1) Reported to WHO. http://www.who.int/csr/disease/avian_influenza/ country/cases_table_2009_02_09/en/index.html.
5. OIE/FAO (April 7-8, 2005) Recommendations of the OIE/FAO International Scientific Conference on Avian Influenza (Paris) Available at www.oie.int/eng/avian_influenza/OIE_FAO_Recom_05.pdf.
6. Alexander DJ (2007) An overview of the epidemiology of avian influenza. Vaccine 25: 5637-5644.
7. Robinson HL, Hunt LA, Webster RG (1993) Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine 11: 957-960.
8. Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, et al. (1993) DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci U S A 90: 11478-11482.
9. Gao W, Soloff AC, Lu X, Montecalvo A, Nguyen DC, et al. (2006) Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. J Virol 80: 1959-1964.
10. Toro H, Tang DC, Suarez DL, Sylte MJ, Pfeiffer J, et al. (2007) Protective avian influenza in ovo vaccination with non-replicating human adenovirus vector. Vaccine 25: 2886-2891.
11. Singh N, Pandey A, Jayashankar L, Mittal SK (2008) Bovine adenoviral vector-based H5N1 influenza vaccine overcomes exceptionally high levels of preexisting immunity against human adenovirus. Mol Ther 16: 965-971.
12. Taylor J, Weinberg R, Kawaoka Y, Webster RG, Paoletti E (1988) Protective immunity against avian influenza induced by a fowlpox virus recombinant. Vaccine 6: 504-508.
13. Beard CW, Schnitzlein WM, Tripathy DN (1991) Protection of chickens against highly pathogenic avian influenza virus (H5N2) by recombinant fowlpox viruses. Avian Dis 35: 356-359.
14. Swayne DE, Garcia M, Beck JR, Kinney N, Suarez DL (2000) Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert. Vaccine 18: 1088-1095.
15. Webster RG, Kawaoka Y, Taylor J, Weinberg R, Paoletti E (1991) Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens. Vaccine 9: 303-308.
16. Crawford J, Wilkinson B, Vosnesensky A, Smith G, Garcia M, et al. (1999) Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes. Vaccine 17: 2265-2274.
17. Yang DG, Chung YC, Lai YK, Lai CW, Liu HJ, et al. (2007) Avian influenza virus hemagglutinin display on baculovirus envelope: cytoplasmic domain affects virus properties and vaccine potential. Mol Ther 15: 989-996.
18. Galarza JM, Latham T, Cupo A (2005) Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challenge. Viral Immunol 18: 244-251.
19. Luschow D, Werner O, Mettenleiter TC, Fuchs W (2001) Protection of chickens from lethal avian influenza A virus infection by live-virus vaccination with infectious laryngotracheitis virus recombinants expressing the hemagglutinin (H5) gene. Vaccine 19: 4249-4259.
20. Veits J, Luschow D, Kindermann K, Werner O, Teifke JP, et al. (2003) Deletion of the non-essential UL0 gene of infectious laryngotracheitis (ILT) virus leads to attenuation in chickens, and UL0 mutants expressing influenza virus haemagglutinin (H7) protect against ILT and fowl plague. J Gen Virol 84: 3343-3352.
21. Ge J, Deng G, Wen Z, Tian G, Wang Y, et al. (2007) Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. J Virol 81: 150-158.
22. Park MS, Steel J, Garcia-Sastre A, Swayne D, Palese P (2006) Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proc Natl Acad Sci U S A 103: 8203-8208.
23. Veits J, Wiesner D, Fuchs W, Hoffmann B, Granzow H, et al. (2006) Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza. Proc Natl Acad Sci U S A 103: 8197-8202.
24. DiNapoli JM, Yang L, Suguitan A Jr, Elankumaran S, Dorward DW, et al. (2007) Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus. J Virol 81: 11560-11568.
25. Krishnamurthy S, Huang Z, Samal SK (2000) Recovery of a virulent strain of newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation. Virology 278: 168-182.
26. Nakaya T, Cros J, Park MS, Nakaya Y, Zheng H, et al. (2001) Recombinant Newcastle disease virus as a vaccine vector. J Virol 75: 11868-11873.
27. Huang Z, Elankumaran S, Panda A, Samal SK (2003) Recombinant Newcastle disease virus as a vaccine vector. Poult Sci 82: 899-906.
28. Huang Z, Elankumaran S, Yunus AS, Samal SK (2004) A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV. J Virol 78: 10054-10063.
29. DiNapoli JM, Kotelkin A, Yang L, Elankumaran S, Murphy BR, et al. (2007) Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogens. Proc Natl Acad Sci U S A 104: 9788-9793.
30. Govorkova EA, Rehg JE, Krauss S, Yen HL, Guan Y, et al. (2005) Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004. J Virol 79: 2191-2198.
31. Rout SN, Samal SK (2008) The large polymerase protein is associated with the virulence of Newcastle disease virus. J Virol 82: 7828-7836.
32. OIE (2004) Manual of Diagnostic Tests and Vaccines for Terrestrial Animals; NEWCASTLE DISEASE. CHAPTER 2.1.15, http://www.oie.int/eng/OIE/ organisation/en_LR.htm.
33. Steel J, Lowen AC, Pena L, Angel M, Solorzano A, et al. (2009) Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza. J Virol 83: 1742-1753.
34. Huang Z, Krishnamurthy S, Panda A, Samal SK (2001) High-level expression of a foreign gene from the most 3'-proximal locus of a recombinant Newcastle disease virus. J Gen Virol 82: 1729-1736.
35. Kolakofsky D, Pelet T, Garcin D, Hausmann S, Curran J, et al. (1998) Paramyxovirus RNA synthesis and the requirement for hexamer genome length: the rule of six revisited. J Virol 72: 891-899.
36. Hierholzer JC, Killington RA (1996) Virus isolation and quantitation. In: Mahy BW, Kangro HI, eds. London, United Kingdom: Virology methods manual Academic Press. pp 25-46.